173 related articles for article (PubMed ID: 21663607)
1. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.
Sentinelli F; Romeo S; Maglio C; Incani M; Burza MA; Scano F; Coccia F; Cossu E; Leonetti F; Baroni MG
Lipids Health Dis; 2011 Jun; 10():93. PubMed ID: 21663607
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
3. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
5. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
Niu TH; Jiang M; Xin YN; Jiang XJ; Lin ZH; Xuan SY
World J Gastroenterol; 2014 Apr; 20(13):3655-62. PubMed ID: 24707151
[TBL] [Abstract][Full Text] [Related]
7. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
8. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
Romeo S; Sentinelli F; Dash S; Yeo GS; Savage DB; Leonetti F; Capoccia D; Incani M; Maglio C; Iacovino M; O'Rahilly S; Baroni MG
Int J Obes (Lond); 2010 Jan; 34(1):190-4. PubMed ID: 19844213
[TBL] [Abstract][Full Text] [Related]
9. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
Kozlitina J; Boerwinkle E; Cohen JC; Hobbs HH
Hepatology; 2011 Feb; 53(2):467-74. PubMed ID: 21274868
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
Yu J; Huang J; Liang Y; Qin B; He S; Xiao J; Wang H; Zhong R
Lipids Health Dis; 2011 Nov; 10():200. PubMed ID: 22054125
[TBL] [Abstract][Full Text] [Related]
13. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
[TBL] [Abstract][Full Text] [Related]
14. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
15. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
[TBL] [Abstract][Full Text] [Related]
17. Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.
Wang J; Ye C; Fei S
Afr Health Sci; 2020 Dec; 20(4):1800-1808. PubMed ID: 34394242
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents.
Jain V; Kumar A; Ahmad N; Jana M; Kalaivani M; Kumar B; Shastri S; Jain O; Kabra M
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):749-758. PubMed ID: 31216264
[TBL] [Abstract][Full Text] [Related]
19. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
